Tag: COAST-V
Positive top-line results for second phase 3 study of Taltz in...
The results of the COAST-W trial demonstrate that Taltz (ixekizumab; Eli Lilly and Company) is a safe and effective treatment for Ankylosing Spondylitis (AS),...